These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 28845026)

  • 1. Marked recovery from glucotoxicity of β-cell function after medical nutrition therapy without pharmacotherapy in type 2 diabetic outpatients with extreme hyperglycemia: a pilot retrospective study.
    Takahara M; Shiraiwa T; Katakami N; Matsuoka TA; Shimomura I
    Endocr J; 2017 Nov; 64(11):1125-1129. PubMed ID: 28845026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of beta-cell function in conjunction with glycemic control after medical nutrition therapy in newly-diagnosed type 2 diabetes mellitus.
    Takahara M; Shiraiwa T; Maeno Y; Yamamoto K; Shiraiwa Y; Yoshida Y; Nishioka N; Katakami N; Shimomura I
    BMC Endocr Disord; 2022 Jun; 22(1):150. PubMed ID: 35658859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of insulin sensitivity, beta-cell function and glycaemic control on initiation of second-line glucose-lowering treatment in newly diagnosed type 2 diabetes.
    Rathmann W; Strassburger K; Bongaerts B; Bobrov P; Kuss O; Müssig K; Markgraf DF; Szendroedi J; Herder C; Roden M;
    Diabetes Obes Metab; 2017 Jun; 19(6):866-873. PubMed ID: 28127851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The capability of glucose toxicity on severe type 2 diabetes.
    Hsieh CH; Hung YJ; He CT; Lee CH; Hung SC; Wang YK; Kuo SW; Pei D
    Endocr Res; 2005; 31(2):149-58. PubMed ID: 16353673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission of hyperglycemia following intensive insulin therapy in newly diagnosed type 2 diabetic patients: a long-term follow-up study.
    Xu W; Li YB; Deng WP; Hao YT; Weng JP
    Chin Med J (Engl); 2009 Nov; 122(21):2554-9. PubMed ID: 19951569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of β-cell function after achievement of optimal glycaemic control via long-term continuous subcutaneous insulin infusion therapy in non-newly diagnosed type 2 diabetic patients with suboptimal glycaemic control.
    Choi SB; Lee JH; Lee JH; Kim S; Han SD; Kim IH; Noh YH
    Diabetes Metab Res Rev; 2013 Sep; 29(6):473-82. PubMed ID: 23592489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetic Retinopathy in Newly Diagnosed Subjects With Type 2 Diabetes Mellitus: Contribution of β-Cell Function.
    Roy Chowdhury S; Thomas RL; Dunseath GJ; Peter R; Rees DA; North RV; Luzio SD; Owens DR
    J Clin Endocrinol Metab; 2016 Feb; 101(2):572-80. PubMed ID: 26652932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between HDL cholesterol levels and beta-cell function in subjects with various degree of glucose tolerance.
    Bardini G; Dicembrini I; Rotella CM; Giannini S
    Acta Diabetol; 2013 Apr; 50(2):277-81. PubMed ID: 21997326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between hemoglobin A1c and blood glucose throughout the day in well-glycemic-controlled medical nutrition therapy alone type 2 diabetic patients.
    Li WH; Xiao XH; Sun Q; Yang GH; Wang H
    Chin Med Sci J; 2006 Jun; 21(2):90-4. PubMed ID: 16845794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The beneficial effect of metformin on β-cell function in non-obese Chinese subjects with newly diagnosed type 2 diabetes.
    Bi Y; Tong GY; Yang HJ; Cai MY; Ma JH; Liang J; Xin B; Miao H; Peng ZH; Zhu DL
    Diabetes Metab Res Rev; 2013 Nov; 29(8):664-72. PubMed ID: 23955995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats.
    Tsujihata Y; Ito R; Suzuki M; Harada A; Negoro N; Yasuma T; Momose Y; Takeuchi K
    J Pharmacol Exp Ther; 2011 Oct; 339(1):228-37. PubMed ID: 21752941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription factor Ets-1 links glucotoxicity to pancreatic beta cell dysfunction through inhibiting PDX-1 expression in rodent models.
    Chen F; Sha M; Wang Y; Wu T; Shan W; Liu J; Zhou W; Zhu Y; Sun Y; Shi Y; Bleich D; Han X
    Diabetologia; 2016 Feb; 59(2):316-24. PubMed ID: 26564177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a combination of oral anti-diabetes drugs with basal insulin therapy on β-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes.
    Mu PW; Chen YM; Lu HY; Wen XQ; Zhang YH; Xie RY; Shu J; Wang MM; Zeng LY
    Diabetes Metab Res Rev; 2012 Mar; 28(3):236-40. PubMed ID: 21898754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BBT improves glucose homeostasis by ameliorating β-cell dysfunction in type 2 diabetic mice.
    Yao XG; Xu X; Wang GH; Lei M; Quan LL; Cheng YH; Wan P; Zhou JP; Chen J; Hu LH; Shen X
    J Endocrinol; 2015 Mar; 224(3):327-41. PubMed ID: 25572265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between insulin resistance and β-cell dysfunction in subphenotypes of prediabetes and type 2 diabetes.
    Færch K; Johansen NB; Witte DR; Lauritzen T; Jørgensen ME; Vistisen D
    J Clin Endocrinol Metab; 2015 Feb; 100(2):707-16. PubMed ID: 25387263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical nutrition therapy for pregnant women with gestational diabetes mellitus-A retrospective cohort study.
    Shi M; Liu ZL; Steinmann P; Chen J; Chen C; Ma XT; Han SH
    Taiwan J Obstet Gynecol; 2016 Oct; 55(5):666-671. PubMed ID: 27751413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.
    Diabetes; 1995 Nov; 44(11):1249-58. PubMed ID: 7589820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo?
    Burén J; Lindmark S; Renström F; Eriksson JW
    Metabolism; 2003 Feb; 52(2):239-45. PubMed ID: 12601640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial short-term intensive insulin therapy as a strategy for evaluating the preservation of beta-cell function with oral antidiabetic medications: a pilot study with sitagliptin.
    Retnakaran R; Qi Y; Opsteen C; Vivero E; Zinman B
    Diabetes Obes Metab; 2010 Oct; 12(10):909-15. PubMed ID: 20920044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fresh pomegranate juice ameliorates insulin resistance, enhances β-cell function, and decreases fasting serum glucose in type 2 diabetic patients.
    Banihani SA; Makahleh SM; El-Akawi Z; Al-Fashtaki RA; Khabour OF; Gharibeh MY; Saadah NA; Al-Hashimi FH; Al-Khasieb NJ
    Nutr Res; 2014 Oct; 34(10):862-7. PubMed ID: 25223711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.